San Francisco, 17 November 2025: The Report Automated NGS Library Preparation Market (2025 - 2030) Size, Share & Trends Analysis Report By Product (Instruments, Kits & Reagents), By Type, By Workflow, By Application, By End-use, By Region, And Segment Forecasts

The global automated NGS library preparation market size is anticipated to reach USD 1,453.8 million by 2030 and is projected to grow at a CAGR of 13.34% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for high-throughput sequencing and the need for efficient and reproducible sample preparation is driving the growth of automated NGS library preparation technologies. These advancements enhance workflow efficiency, minimize human errors, and provide scalability for various genomic applications, including clinical diagnostics, oncology research, and drug discovery.

The COVID-19 pandemic further accelerated the adoption of automated NGS library preparation solutions as laboratories worldwide sought streamlined and scalable sequencing workflows. The surge in genomic surveillance and infectious disease research during the pandemic emphasized the need for automation of sample preparation. Moreover, collaborations between research institutions, biotechnology companies, and healthcare providers led to significant technological advancements, boosting the market’s expansion.

In addition, the rising availability of automated NGS library preparation services has further fueled market growth. Contract research organizations (CROs) and Contract Manufacturing Organizations (CMOs) are essential in supporting the development and commercialization of sequencing-based applications. These service providers offer expertise in clinical trials, regulatory compliance, and scalable manufacturing, facilitating faster and more cost-effective deployment of automated NGS solutions. Automation is becoming increasingly essential as the demand for NGS expands across various fields.

However, integrating automation into NGS library preparation workflows can be complex, involving challenges like equipment compatibility, software integration, and protocol adaptation. It also requires training personnel to manage and maintain advanced systems. Despite these hurdles, successful implementation offers substantial benefits, including enhanced scalability, minimized errors, and increased throughput-positioning automation as a strategic investment for laboratories aiming to stay competitive in the fast-evolving genomics space.

Request sample report of Automated NGS Library Preparation Market@ https://www.grandviewresearch.com/industry-analysis/automated-ngs-library-preparation-market-report/request/rs1

The demand for genomic research in clinical diagnostics, drug discovery, and personalized medicine drives the automated NGS library preparation industry. The growing need for high-throughput sequencing in cancer genomics and rare disease studies accelerates automation adoption. Computerized workflows improve efficiency, reduce human error, and enhance reproducibility in sequencing experiments. The increasing use of whole-genome and targeted sequencing further fuels the need for automated solutions. The expansion of genomic databases and bioinformatics advancements also contribute to the industry's growth.

The COVID-19 pandemic served as a strategic accelerator for the automated NGS library preparation industry, driving rapid adoption of automation to meet unprecedented demands for high-throughput genomic testing. Manual processes proved insufficient for large-scale sequencing needs, prompting laboratories to invest in scalable, automated solutions that enhanced efficiency, consistency, and turnaround time. Heightened global focus on genomic surveillance, coupled with increased public and private funding, reinforced the value of automation in sustaining operations during workforce constraints. As a result, automation transitioned from a technical enhancement to a business-critical capability across clinical, academic, and commercial sequencing environments.

Precision medicine is revolutionizing healthcare by tailoring treatments to an individual’s genetic profile. Next-Generation Sequencing (NGS) advances allow for rapid and cost-effective genetic analysis. This approach enhances disease diagnosis, prognosis, and therapy selection. Cancer treatment, rare diseases, and pharmacogenomics particularly benefit from precision medicine. The demand for high-throughput sequencing is rising to meet clinical and research needs. This shift drives innovation in sequencing platforms and bioinformatics tools.

Automation in NGS library preparation improves efficiency, reproducibility, and throughput. Robotic systems streamline complex processes such as DNA/RNA extraction and sample preparation. AI-driven solutions optimize workflows by minimizing human error and maximizing precision. Automated liquid handling ensures consistency in reagent distribution and sample mixing. These advancements reduce turnaround time and costs for genomic research. As a result, high-throughput sequencing becomes more accessible and scalable.